In the TRACK-D trial , @ patients with type @ diabetes and concomitant chronic kidney disease ( CKD ) who underwent coronary/peripheral arterial angiography with or without percutaneous intervention were randomized to short-term ( @ days before and @ days after procedure ) rosuvastatin therapy or standard-of-care .